ARCHIVES

Carbone Heads Chairmen’s Group

This article is from The Cancer Letter archive.

Vol. 04 No. 26 | June 30, 1978

Download PDF Visit The Full Archive

Related Articles

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

August 6, 2010

NCI CTEP Approved Trials For the Month of January

January 31, 2014

Cancer Meetings Listed For Next Three Months

June 25, 1993

OCC Proposes Plan To Educate Patients, Physicians On Value Of Clinical Trials

January 8, 1988